Neuronetics (STIM) SEC Filings & 10K Form

$3.74
-0.06 (-1.58%)
(As of 04/22/2024 ET)

Recent Neuronetics SEC Filings

DateFilerForm TypeView
04/01/2024
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13G
03/25/2024
3:59 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
8:44 PM
Neuronetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:02 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:10 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:16 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
4:33 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
4:21 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:23 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:19 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:35 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
10:46 AM
Kent Lake Capital LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/14/2024
9:21 AM
CANNELL CAPITAL LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/13/2024
5:00 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
10:10 AM
Archon Capital Management LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/09/2024
2:39 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
4:41 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:42 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
5:19 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:44 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:24 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:00 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
2:33 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
2:13 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
6:42 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
10:09 AM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
10:24 AM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
11:28 AM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
3:30 PM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
4:10 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:12 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
2:16 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2023
2:20 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2023
3:14 PM
Kent Lake Capital LLC (Filed by)
Neuronetics (Subject)
Form SC 13G
09/20/2023
5:15 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4/A
09/11/2023
11:08 AM
CANNELL CAPITAL LLC (Filed by)
Neuronetics (Subject)
Form SC 13G
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…
08/11/2023
4:56 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2023
6:50 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
5:15 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
2:36 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/20/2023
2:14 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
2:21 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2023
7:35 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
2:21 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
7:04 AM
CANNELL CAPITAL LLC (Filed by)
Neuronetics (Subject)
Form SC 13D/A
06/01/2023
2:39 PM
CANNELL CAPITAL LLC (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
8:04 PM
JAEGER WILFRED E (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
8:05 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:54 PM
Neuronetics (Issuer)
Rosengarten Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:56 PM
Capper Joseph H (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:58 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:59 PM
CONLEY SHERYL L (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
10:36 AM
BAKEWELL JOHN K (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2023
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:STIM) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners